Published in Semin Respir Infect on June 01, 1986
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun (1996) 2.16
Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun (1987) 2.07
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A (1988) 1.61
Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun (1989) 1.46
Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane. Infect Immun (1988) 1.27
Defensins mediate the microbicidal activity of human neutrophil granule extract against Acinetobacter calcoaceticus. Infect Immun (1987) 1.27
In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun (1990) 1.13
Insect immunity: expression of the two major inducible antibacterial peptides, defensin and diptericin, in Phormia terranovae. EMBO J (1990) 1.10
Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide. J Biol Chem (2012) 1.03
Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect Immun (2009) 1.01
In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest (1991) 1.01
The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. Trans Am Ophthalmol Soc (2002) 0.90
Antimicrobial peptides and proteins of the horse--insights into a well-armed organism. Vet Res (2011) 0.86
The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3. Infect Immun (2008) 0.85
The repertoire of equine intestinal alpha-defensins. BMC Genomics (2009) 0.81
Interaction of Candida albicans with human leukocytes and serum. J Bacteriol (1969) 9.19
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest (1969) 7.61
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Phagocytosis by human monocytes. Blood (1968) 3.96
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A (1990) 3.90
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett (1996) 3.39
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Antifungal effects of peroxidase systems. J Bacteriol (1969) 3.24
Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun (1980) 3.13
Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A (1998) 3.02
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Defensins. Eur J Haematol (1990) 2.88
Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science (1991) 2.71
Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect Immun (1975) 2.68
NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest (1975) 2.62
Defensins. Curr Opin Immunol (1994) 2.55
Defensins. Pharmacol Ther (1995) 2.52
Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50
Defensins: endogenous antibiotic peptides of animal cells. Cell (1991) 2.45
Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci (1994) 2.43
Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J (2000) 2.41
Structure, function, and membrane integration of defensins. Curr Opin Struct Biol (1995) 2.40
Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun (1992) 2.39
Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity. J Clin Invest (1971) 2.35
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun (1983) 2.33
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J Virol (1985) 2.31
The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest (1975) 2.26
Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest (1972) 2.25
Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun (1990) 2.25
Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol (1995) 2.25
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest (1988) 2.18
Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun (1996) 2.16
Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun (1987) 2.16
Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16
Assessment of chlorination by human neutrophils. Nature (1983) 2.12
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J (1996) 2.03
Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci (1979) 2.02
Mouse neutrophils lack defensins. Infect Immun (1992) 2.01
In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood (1986) 2.01
The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol (1998) 1.98
Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun (1997) 1.96
Antimicrobial peptides of vertebrates. Curr Opin Immunol (1998) 1.94
Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun (1994) 1.93
Neutrophils and host defense. Ann Intern Med (1988) 1.92
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun (1985) 1.89
Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol (1994) 1.88
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol (1996) 1.87
In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis (1986) 1.84
Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol Biol (1997) 1.79
Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans. Infect Immun (1980) 1.79
Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun (1994) 1.78
Rubidium release: a rapid and sensitive assay for amphotericin B. J Infect Dis (1976) 1.76
Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys J (1997) 1.76
Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest (1995) 1.75
Phagolysosomal pH of human neutrophils. Blood (1984) 1.75
Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun (1997) 1.75
Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys J (1997) 1.68
Susceptibility of Neisseria gonorrhoeae to protegrins. Infect Immun (1996) 1.65
Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry (2000) 1.64
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol (1988) 1.64
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Structure and diversity of the murine cryptdin gene family. Genomics (1994) 1.62
Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes. Infect Immun (1981) 1.61
Fungicidal properties of a chymotrypsin-like cationic protein from human neutrophils: adsorption to Candida parapsilosis. Infect Immun (1977) 1.61
Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A (1988) 1.61
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology (1994) 1.53
Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun (1981) 1.52
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun (1989) 1.46